- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Jenburkt Pharmaceuticals Ltd — Board Meeting, 28-10-2025: Board Meeting
28-10-2025 | 04:48 pm
28-10-2025 | 04:48 pm
Jenburkt Pharma's Board approved the financial results for the quarter and half-year. Q2 Revenue from Operations hit ₹45.56 Cr, with Profit After Tax at ₹10.16 Cr. EPS for the quarter stood at ₹23.03. H1 Revenue reached ₹81.08 Cr, PAT ₹17.96 Cr.
No comments yet. Be the first to comment!